Skip to content

Screener

Eligibility screening

A Clinical Trial of Sacituzumab Tirumotecan (MK-2870) for Bladder Cancer

Sponsored by Merck Sharp & Dohme LLCStudy detailsClinicalTrials.gov

4 US sites in CA, FL, IL, MD

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.